Take the First Step If youre struggling with weight management, metabolic health, or elevated liver markers, Semaglutide may be a transformative option for you
Theyre looking for a more durable approach
FDA prescribing information for both semaglutide and tirzepatide notes cholelithiasis and cholecystitis (gallbladder inflammation) as adverse events
This difference raises concerns about safety and efficacy, making it vital for patients to approach compounded options with caution
Genome-wide association analyses have detected critical polymorphisms in genes regulating hepatic lipid handling, including patatin-like phospholipase domain-containing 3 (PNPLA3) and transmembrane 6 superfamily member 2 (TM6SF2), which promote intrahepatic triglyceride accumulation by impairing lipid remodeling or very-low-density lipoprotein (VLDL) secretion [16,17]
Discuss this distinction with your provider before choosing